We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GGRM:IDXPT Gudang Garam Tbk Analysis

Data as of 2026-08-08 - not real-time

IDR 21,725.00

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

PT Gudang Garam Tbk trades at IDR 21,725.00, with its short-term moving averages stacked above the longer-term ones — a bullish trend structure. Over a rolling month the price has gained 31.3%. RSI sits at 81.2, which reads as overbought, and MACD momentum is bullish. Price has been bracketed by support at IDR 16,200.00 and resistance at IDR 21,800.00.
Valuation screens as fair, on a P/E of 9.5 with no clean sector comparison available. Sell-side targets cluster 20.4% below the current quote. The 3.68% dividend yield looks covered by current payout levels.
Risk comes out at 4 of a possible 10, a moderate reading. With 30-day volatility of 37.4%, a beta of 0.50 and a maximum drawdown of 27.3%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Timeframes disagree: the short-term read is buy while the long-term read is hold, conviction 4 out of 10.

Top Market Events

Get the latest PT Gudang Garam Tbk GGRM.JK stock news and headlines to help you in your trading and investment...Barron's1monGudang GaramPT Gudang Garam Tbk engages in the manufacture and trade of cigarettes.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • RSI at 81.2 signals overbought conditions
  • Trading above the 200-day average of 15502.62

Medium Term

1–3 years
Positive
Model confidence: 5/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • RSI at 81.2 signals overbought conditions
  • Trading above the 200-day average of 15502.62

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Analyst targets imply -20.4% versus the current price
  • Revenue contracting at -1.1%
  • P/E ratio of 9.5

Key Metrics & Analysis

Financial Health

Revenue Growth-1.10%
Profit Margin5.12%
P/E Ratio9.5
ROE7.06%
ROA4.93%
P/B Ratio0.7
Op. Cash FlowIDR12227.3B
Free Cash FlowIDR10514.3B

Technical Analysis

TrendBullish
RSI81.2
SupportIDR 16,200.00
ResistanceIDR 21,800.00
MA 20IDR 18,341.25
MA 50IDR 16,937.00
MA 200IDR 15,502.63
MACDBullish
VolumeIncreasing
Fear & Greed Index94.82

Valuation

Fair ValueIDR 74,481.79
Target PriceIDR 17,283.33
Upside/Downside-20.44%
GradeFair
TypeValue
Dividend Yield3.68%

Risk Assessment

Beta0.50
Volatility37.37%
Sector RiskLow
Reg. RiskMedium
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.